Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1287 results for "sun pharma"

Sun Pharma open to fresh acquisitions: Dilip S Shanghvi
Business Standard

Sun Pharma chief Dilip S Shanghvi expects Ranbaxy deal to be c...

HYDERABAD: Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating that the key challenge before the combined entity would be to rebuild the confidence of ... Economic Times, 4 hours ago
Sun Pharma open to fresh acquisitions: Dilip S Shanghvi Business Standard, 21 hours ago
India Infoline

Sun Pharma, Ranbaxy integration to be over by Feb-end: Dilip Shanghvi

Sun Pharmaceuticals Ltd is likely to complete the integration of Ranbaxy by end of next month if all regulatory approvals come as expected, according to its founder - Managing Director, Dilip S Shanghvi. Speaking to newspersons on the sidelines of ...
 Hindu Business Line5 hours ago Sun Pharma continues winning streak, up 4%  India Infoline3 days ago Sun Pharma jumps on block deal  India Infoline6 days ago Sun Pharma, Ranbaxy stock up on CCI merger approval  India Infoline1 month ago

Book authoured by late Dr K Anji Reddy released

'An Unfinished Agenda: My Life in the Pharmaceutical Industry', a book written by Late Dr K Anji Reddy (1941-2013), founder-Chairman of Dr Reddy's Laboratories Ltd, was released here on Friday. Speaking at the launch function, K Satish Reddy, ...
 Hindu Business Line1 day ago See opportunity in Sun pharma, Lupin: Sudarshan Sukhani  Money Control3 days ago Buy Sun Pharma, advises Sudarshan Sukhani  Money Control6 days ago Pharma deals: of opportunities & uncertainties  Hindu Business Line2 weeks ago

Is Shanghvi readying a succession plan?

HYDERABAD: Is the 59-year-old Sun Pharma founder, Dilip Shanghvi, preparing a succession plan? A hint to this effect came from the pharma baron himself on Friday when he articulated his desire to pursue his long-cherished interests. When asked if ...
 Times of India1 day ago Is Sun Pharma founder Dilip Shanghvi readying a succession plan?  Economic Times1 day ago Is Sun Pharma's Shanghvi readying a succession plan?  Economic Times1 day ago 2014: Blockbuster year for Sun Pharma's Dilip Shanghvi  Money Control3 weeks ago

DLF climbs up 2.85% on NSE

Sun Pharma Industries notched up gains of 4.40 per cent to lead the pack on the NSE at noon on Thursday. The scrip was trading at Rs 924.95 as against Rs 885.95 at close yesterday. DLF built gains of 2.85 per cent to trade at Rs 147.80 as against ...
 Hindu Business Line2 days ago DLF extends gains, up nearly 3% on NSE  Hindu Business Line3 days ago
Money Control

Sensex, Nifty hold early gains; Sun Pharma, Axis top movers

Sun Pharma topped the buying list in Sensex, up 4 percent. Shares of Infosys, Axis Bank, Tata Motors, ONGC, HUL, Dr Reddy's Labs and Cipla gained 1-2.4 percent whereas Reliance Industries and NTPC declined 1.5-2 percent.
 Money Control3 days ago Nifty ends at 8201; TCS HDFC gainers, Maruti falls 1%  Money Control4 weeks ago Coal India, Maruti gainers; Sensex, Nifty sluggish  Money Control1 month ago Nifty falls below 8300; Cairn, ONGC, Sesa under pressure  Money Control1 month ago
Business Standard

Sun Pharma holds on to gains of 3.72% on BSE

Sun Pharma industries held on to its firm undertone in late trading on the BSE on Thursday. At 2.40 pm it was trading at Rs 919 as against 886.05 at the finish on Wednesday. This was a gain of 3.72 per cent. Axis Bank traded up 3.08 per cent to ...
 Hindu Business Line3 days ago Sensex ends 105 pts down; SAIL slips 2%, ITC gains 2%  Money Control1 month ago TCS, Sun Pharma, Infosys, Cipla to get astro support: Gupta  Money Control1 month ago Sun Pharma gains after Taro reports good Q2 earnings  Business Standard2 months ago

Hold Sun Pharma Advanced Research Company: Gaurav Bissa

Gaurav Bissa of LKP Securities recommends holding Sun Pharma Advanced Research Company with a target of rs 210-215.
 Money Control1 week ago Sun Pharma Advanced Research's Q3 results on January 30, 2015  Money Control1 week ago Mumbai Bourse: Press Release From Sun Pharma Advanced Research  iMarketReports1 week ago Sun Pharma Advanced Research Company to announce Q3 results on Jan 30, 2015  Equity Bulls1 week ago

Six in Sixty: Stocks you should keep on your radar

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Suzlon, Sun Pharma, Ranbaxy, HUL, ITC, Zee Entertainment, Cairn India, Tata Motors
 Money Control3 days ago Here are top 10 stocks to watch on December 11  Money Control1 month ago Here are top 10 stocks to focus on December 9  Money Control1 month ago
Money Control

Stocks in news: TCS, Kesoram, SpiceJet, Sasken, Den Network

TCS | Kotak Mahindra Bank | Cairn India | SpiceJet | Jet Airways | Den Networks | Sun Pharma | Mindtree | Central Bank of India | Muthoot Finance | YES Bank | Punj Lloyd | Adani Power | Lanco Infratech | Oriental Bank of Commerce | Sasken Communications | MRF ...
 Money Control5 days ago Sensex, Nifty, rupee strengthen; HDFC, TCS Infosys down  Money Control6 days ago Sensex, Nifty fall 1%; ITC, ONGC, Sun Pharma outperform  Money Control1 month ago Tata Mutual Fund sells IT, metal, oil gas; buys bank  Moneycontrol.com5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma
Get updated on latest news & your favorite topics right in your inbox!
More     Less